CoChat

Novel Entries in a Fungal Biofilm Matrix Encyclopedia

Open access

The DOI matches its Crossref record; 95 of the 98 references it cites were found in a registry or an index.

Abstract

Virulence of Candida is linked with its ability to form biofilms. Once established, biofilm infections are nearly impossible to eradicate. Biofilm cells live immersed in a self-produced matrix, a blend of extracellular biopolymers, many of which are uncharacterized. In this study, we provide a comprehensive analysis of the matrix manufactured by Candida albicans both in vitro and in a clinical niche animal model. We further explore the function of matrix components, including the impact on drug resistance. We uncovered components from each of the macromolecular classes (55% protein, 25% carbohydrate, 15% lipid, and 5% nucleic acid) in the C. albicans biofilm matrix. Three individual polysaccharides were identified and were suggested to interact physically. Surprisingly, a previously identified polysaccharide of functional importance, β-1,3-glucan, comprised only a small portion of the total matrix carbohydrate. Newly described, more abundant polysaccharides included α-1,2 branched α-1,6-mannans (87%) associated with unbranched β-1,6-glucans (13%) in an apparent mannan-glucan complex (MGCx). Functional matrix proteomic analysis revealed 458 distinct activities. The matrix lipids consisted of neutral glycerolipids (89.1%), polar glycerolipids (10.4%), and sphingolipids (0.5%). Examination of matrix nucleic acid identified DNA, primarily noncoding sequences. Several of the in vitro matrix components, including proteins and each of the polysaccharides, were also present in the matrix of a clinically relevant in vivo biofilm. Nuclear magnetic resonance (NMR) analysis demonstrated interaction of aggregate matrix with the antifungal fluconazole, consistent with a role in drug impedance and contribution of multiple matrix components. IMPORTANCE This report is the first to decipher the complex and unique macromolecular composition of the Candida biofilm matrix, demonstrate the clinical relevance of matrix components, and show that multiple matrix components are needed for protection from antifungal drugs. The availability of these biochemical analyses provides a unique resource for further functional investigation of the biofilm matrix, a defining trait of this lifestyle.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mbio.01333-14

Cites

95 of 96 references verified1 citation errors · 0 not checkable

Statistics

Figures

FIG 1 Impact of the matrix isolation process on C. albicans biofilm and planktonic cells. (A) The matrix collection process visibly removes matrix, leaving fungal cells intact based upon scanning electron microscopy (SEM) of the biofilm pre- and postcollection. The scale bar represents 50 µm. (B) The matrix collection process does not visibly impact the cell wall of fungi based upon TEM of postcollection cells. The scale bar represents 1 µm. (C) The matrix processing does not extract cell wall components from planktonic (nonbiofilm) cells.
FIG 1 Impact of the matrix isolation process on C. albicans biofilm and planktonic cells. (A) The matrix collection process visibly removes matrix, leaving fungal cells intact based upon scanning electron microscopy (SEM) of the biofilm pre- and postcollection. The scale bar represents 50 µm. (B) The matrix collection process does not visibly impact the cell wall of fungi based upon TEM of postcollection cells. The scale bar represents 1 µm. (C) The matrix processing does not extract cell wall components from planktonic (nonbiofilm) cells.CC BY-NC-SA · PubMed Central
FIG 2 Chromatographic fractionation and NMR analysis of carbohydrates from the C. albicans biofilm extracellular matrix. (A) Initial fractionation employing flash size exclusion chromatography on the HiPrep 26/10 Desalting Sephadex G-25 Fine column. The matrix sample was separated into the Man/Glc-rich HMW fraction (38.3%) and the Ara-rich LMW fraction (61.7%). Proteins were detected at 280 nm. (B) Fractionation of the HMW fraction on the weak anion exchanger HiPrep 16/10 DEAE FF column resulted in separation of uncharged protein-free polysaccharides from charged proteins and glycoproteins. Polysaccharides were eluted in the flowthrough fraction (shown as FT), whereas multiple (glyco) protein peaks, D1 to D8, were separated in the applied salt gradient (dashed line with larger spaces) as reflected by increasing conductivity (dashed line with smaller spaces). (C) Purification of neutral polysaccharides in gel filtration chromatography on the HighPrep 16/60 Sephacryl S-300 HR column. This procedure yielded a total of 22 individual polysaccharide-positive peaks, F1 to F22. (D) Size exclusion column calibration with a set of Leuconostoc species dextran standards at the following molecular weights: 100, 70, 40, 25, and 6. Positions of the select purified polysaccharides, F2, F5, F10, F14, F16, and F17, are indicated by reverse triangles. (E) Comparison of the 500-MHz 1H NMR spectra of representative purified matrix neutral polysaccharides, F2, F5, F10, F14, F16, and F17, from the C. albicans biofilm matrix.
FIG 2 Chromatographic fractionation and NMR analysis of carbohydrates from the C. albicans biofilm extracellular matrix. (A) Initial fractionation employing flash size exclusion chromatography on the HiPrep 26/10 Desalting Sephadex G-25 Fine column. The matrix sample was separated into the Man/Glc-rich HMW fraction (38.3%) and the Ara-rich LMW fraction (61.7%). Proteins were detected at 280 nm. (B) Fractionation of the HMW fraction on the weak anion exchanger HiPrep 16/10 DEAE FF column resulted in separation of uncharged protein-free polysaccharides from charged proteins and glycoproteins. Polysaccharides were eluted in the flowthrough fraction (shown as FT), whereas multiple (glyco) protein peaks, D1 to D8, were separated in the applied salt gradient (dashed line with larger spaces) as reflected by increasing conductivity (dashed line with smaller spaces). (C) Purification of neutral polysaccharides in gel filtration chromatography on the HighPrep 16/60 Sephacryl S-300 HR column. This procedure yielded a total of 22 individual polysaccharide-positive peaks, F1 to F22. (D) Size exclusion column calibration with a set of Leuconostoc species dextran standards at the following molecular weights: 100, 70, 40, 25, and 6. Positions of the select purified polysaccharides, F2, F5, F10, F14, F16, and F17, are indicated by reverse triangles. (E) Comparison of the 500-MHz 1H NMR spectra of representative purified matrix neutral polysaccharides, F2, F5, F10, F14, F16, and F17, from the C. albicans biofilm matrix.CC BY-NC-SA · PubMed Central
FIG 3 Structure elucidation of low- and high-molecular-weight mannans, F17 and F2, isolated from the C. albicans biofilm matrix. The NMR spectra of F17 polymer showed several α- and β-Man spin systems and two β-Glc spin systems as reflected by HSQC (A) and NOESY (B) data. Based on these data, F17 mannan consisted of an α-1→6-linked backbone that had every second or third backbone mannan residue substituted with α-1→2-linked side chains containing on average 2 to 3 Man residues. The NMR spectra of F2 showed only α- and β-mannan spin systems as reflected by HSQC (C) and NOESY (D) data. Based on these data, F2 mannan consisted of an α-1→6-linked backbone that had every second or third backbone Man residue substituted with α-1→2-linked side chains containing on average 3 to 4 mannosyl residues. (F) Predicted structures of the C. albicans biofilm matrix neutral polysaccharides: α-1,2 branched α-1,6-mannans, β-1,6- and β-1,3-glucans. G and M denote glucan and mannan, whereas HMW and LMW refer to high- and low-molecular-weight polysaccharide homologue series, respectively. Values in parentheses represent a percentage content of each sugar type in the total neutral polysaccharide pool in the matrix. (G) SAXS 1D scattering profiles for the F20 (black) and F21 (red) fractions. (H) Average low-resolution dummy atom model of F20 (green) generated from 20 independent DAMMIF runs overlaid with a mannan with a molecular weight of 6.8 (blue) that has the branching distributions proposed in the legend to panel F.
FIG 3 Structure elucidation of low- and high-molecular-weight mannans, F17 and F2, isolated from the C. albicans biofilm matrix. The NMR spectra of F17 polymer showed several α- and β-Man spin systems and two β-Glc spin systems as reflected by HSQC (A) and NOESY (B) data. Based on these data, F17 mannan consisted of an α-1→6-linked backbone that had every second or third backbone mannan residue substituted with α-1→2-linked side chains containing on average 2 to 3 Man residues. The NMR spectra of F2 showed only α- and β-mannan spin systems as reflected by HSQC (C) and NOESY (D) data. Based on these data, F2 mannan consisted of an α-1→6-linked backbone that had every second or third backbone Man residue substituted with α-1→2-linked side chains containing on average 3 to 4 mannosyl residues. (F) Predicted structures of the C. albicans biofilm matrix neutral polysaccharides: α-1,2 branched α-1,6-mannans, β-1,6- and β-1,3-glucans. G and M denote glucan and mannan, whereas HMW and LMW refer to high- and low-molecular-weight polysaccharide homologue series, respectively. Values in parentheses represent a percentage content of each sugar type in the total neutral polysaccharide pool in the matrix. (G) SAXS 1D scattering profiles for the F20 (black) and F21 (red) fractions. (H) Average low-resolution dummy atom model of F20 (green) generated from 20 independent DAMMIF runs overlaid with a mannan with a molecular weight of 6.8 (blue) that has the branching distributions proposed in the legend to panel F.CC BY-NC-SA · PubMed Central
FIG 4 Detection of α-1,2 branched α-1,6-mannan, β-1,6-glucan, and β-1,3-glucan in the C. albicans biofilm matrix using an in vitro biofilm model (A to D) and the in vivo rat catheter biofilm model (E to H). The scale bars in panels A, E, F, and G are 50 µm. (A) In vitro biofilm community of yeast and hyphae visualized using a calcofluor white stain. (B) Detection of α-1,2 branched α-1,6-mannan in the in vitro biofilm matrix using anti-α-1,2 branched α-1,6-mannan monoclonal antibody fluorescently labeled with FITC. (C) Detection of β-1,6-glucan in the in vitro biofilm matrix using anti-β-1,6-glucan monoclonal antibody fluorescently labeled with rhodamine. (D) An overlay of both stains showed extracellular staining throughout the in vitro biofilm thickness, and the yellow color is consistent with colocalization. The scale bar is 200 µm. (E) Detection of α-1,2 branched α-1,6-mannan in the in vivo rat catheter biofilm matrix. CL indicates catheter lumen. (F) Detection of β-1,6-glucan in the in vivo rat catheter biofilm matrix. (G) An overlay of both stains showed extracellular staining throughout the biofilm thickness. (H) Immuno-TEM of biofilm scraped from the catheter model identified β-1,3-glucan using gold particle-labeled antibodies. As indicated by arrows, β-1,3-glucan was sparsely scattered throughout the extracellular matrix, consistent with the modest concentration of this polysaccharide relative to other components. The scale bar is 0.5 µm.
FIG 4 Detection of α-1,2 branched α-1,6-mannan, β-1,6-glucan, and β-1,3-glucan in the C. albicans biofilm matrix using an in vitro biofilm model (A to D) and the in vivo rat catheter biofilm model (E to H). The scale bars in panels A, E, F, and G are 50 µm. (A) In vitro biofilm community of yeast and hyphae visualized using a calcofluor white stain. (B) Detection of α-1,2 branched α-1,6-mannan in the in vitro biofilm matrix using anti-α-1,2 branched α-1,6-mannan monoclonal antibody fluorescently labeled with FITC. (C) Detection of β-1,6-glucan in the in vitro biofilm matrix using anti-β-1,6-glucan monoclonal antibody fluorescently labeled with rhodamine. (D) An overlay of both stains showed extracellular staining throughout the in vitro biofilm thickness, and the yellow color is consistent with colocalization. The scale bar is 200 µm. (E) Detection of α-1,2 branched α-1,6-mannan in the in vivo rat catheter biofilm matrix. CL indicates catheter lumen. (F) Detection of β-1,6-glucan in the in vivo rat catheter biofilm matrix. (G) An overlay of both stains showed extracellular staining throughout the biofilm thickness. (H) Immuno-TEM of biofilm scraped from the catheter model identified β-1,3-glucan using gold particle-labeled antibodies. As indicated by arrows, β-1,3-glucan was sparsely scattered throughout the extracellular matrix, consistent with the modest concentration of this polysaccharide relative to other components. The scale bar is 0.5 µm.CC BY-NC-SA · PubMed Central
FIG 5 Fluconazole sequestration and binding to the C. albicans biofilm extracellular matrix. (A) Sequestration of H3-labeled fluconazole in intact biofilms and matrix-deprived biofilms demonstrated a decreased accumulation of the drug intracellularly and in cell walls in intact biofilms containing the matrix. (B) Fluconazole interactions with the matrix studied by one-dimensional 1H NMR at 600 MHz determined as broadening of chemical shift peaks characteristic of protons present in the azole rings of fluconazole. Individual spectra correspond to the following matrix concentrations: (i) 0.11 mg/ml, (ii) 0.45 mg/ml, (iii) 1.28 mg/ml, (iv) 1.81 mg/ml, and (v) 2.26 mg/ml. (C) No binding saturation in the drug/matrix was observed, which suggests the participation of multiple matrix components with different affinity levels for fluconazole in this binding process. (D) No interactions between fluconazole and purified matrix glucomannan conjugates were identified, which suggests that either a combination of sugars or other nonsugar components in the matrix are responsible for drug sequestration.
FIG 5 Fluconazole sequestration and binding to the C. albicans biofilm extracellular matrix. (A) Sequestration of H3-labeled fluconazole in intact biofilms and matrix-deprived biofilms demonstrated a decreased accumulation of the drug intracellularly and in cell walls in intact biofilms containing the matrix. (B) Fluconazole interactions with the matrix studied by one-dimensional 1H NMR at 600 MHz determined as broadening of chemical shift peaks characteristic of protons present in the azole rings of fluconazole. Individual spectra correspond to the following matrix concentrations: (i) 0.11 mg/ml, (ii) 0.45 mg/ml, (iii) 1.28 mg/ml, (iv) 1.81 mg/ml, and (v) 2.26 mg/ml. (C) No binding saturation in the drug/matrix was observed, which suggests the participation of multiple matrix components with different affinity levels for fluconazole in this binding process. (D) No interactions between fluconazole and purified matrix glucomannan conjugates were identified, which suggests that either a combination of sugars or other nonsugar components in the matrix are responsible for drug sequestration.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 96 references

Cited by

See all 318

Metadata

Authors
Zarnowski, R., Westler, W. M., Lacmbouh, G. A., Marita, J. M., Bothe, J. R., Bernhardt, J., Lounes-Hadj Sahraoui, A., Fontaine, J., Sanchez, H., Hatfield, R. D., Ntambi, J. M., Nett, J. E., Mitchell, A. P., & Andes, D. R.
Affiliations
  • Department of Medicine, Infectious Diseases, University of Wisconsin, Madison, Wisconsin, USA
  • University of Wisconsin–Madison (US)
  • U.S. Dairy Forage Research Center (US)
  • Universität Greifswald (DE)
  • Université du Littoral Côte d’Opale, Unité de Chimie Environnementale at Interactions sur le Vivant, Calais, France
  • Université du littoral côte d'opale (FR)
  • Carnegie Mellon University (US)
Corresponding author
Andes, David R.
Venue
mBio
Published
2014-08-29
Volume
5
Issue
4
Pages
e01333-14
ISSN
  • 2150-7511 (ISSN-L)
  • 2161-2129
OpenAlex
W2149297795
Cited by
315
References
98
Citations by year
2026: 18 · 2025: 24 · 2024: 23 · 2023: 23 · 2022: 31 · 2021: 27 · 2020: 34 · 2019: 30 · 2018: 26 · 2017: 27 · 2016: 29 · 2015: 19 · 2014: 4
FWCI
18.51
Type
journal article
Language
en
Open access
Licence
Locations
  • mBio (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
  • HAL (submittedVersion, cc-by-nc-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by-nc-sa)
  • KiltHub Repository
Funders
  • National Science Foundation (8415048, OIA‐9977486, 9214394)
  • U.S. Department of Energy
  • U.S. Department of Agriculture
  • University of Georgia
  • National Institutes of Health (5f32gm010399-02, NIH-R01, 2p41rr005351-21)
  • National Heart, Lung, and Blood Institute (T32HL007899)
  • National Institute of General Medical Sciences (P41GM10399)
  • National Institute of Allergy and Infectious Diseases (R01AI067703, R01AI073289)
  • National Center for Research Resources (RR-02781, S10RR002781, P41RR002301, S10RR008438, S10RR027000, P41-RR02301, RR-08438, P41-RR005351)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Keywords
Candida albicans, fungal biofilms, biofilm matrix composition, β-1,6-glucan, β-1,3-glucan, glycerolipids, antifungal resistance, fluconazole, virulence
MeSH terms
Antifungal Agents, Candida albicans, Fungal Proteins, Gene Expression Regulation, Fungal, Biofilms, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel Entries in a Fungal Biofilm Matrix Encyclopedia. https://app.cochat.ai/papers/10.1128/mbio.01333-14
The paper
Zarnowski, R., Westler, W. M., Lacmbouh, G. A., Marita, J. M., Bothe, J. R., Bernhardt, J., Lounes-Hadj Sahraoui, A., Fontaine, J., Sanchez, H., Hatfield, R. D., Ntambi, J. M., Nett, J. E., Mitchell, A. P., & Andes, D. R. (2014). Novel Entries in a Fungal Biofilm Matrix Encyclopedia. mBio. https://doi.org/10.1128/mbio.01333-14

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.